ALLMedicine™ Aphthous Ulcers Center

Dec 1st, 2022 - Most available antiseptic solutions have strong antibacterial effects, but many also possess major cytotoxic effects on gingival fibroblasts, osteoblasts, osteoprogenitor cells, and/or epithelial cells. A novel VEGA Oral Care Recovery Kit (StellaL...

Oct 26th, 2022 - Behçet's disease (BD) is an autoimmune disease presented with recurrent oral aphthous ulcers, genital ulcers, uveitis and skin lesions. The cutaneous manifestations are often refractory and more resistant to conventional therapy. This report provi...

Oct 19th, 2022 - This case report describes a 15-year-old female who presented with acute onset of painful genital ulcers. She denied being sexually active and tested positive for severe acute respiratory coronavirus 2 five days prior. Associated symptoms on days ...

Oct 6th, 2022 - Practice Essentials Behçet disease is a rare vasculitic disorder that is characterized by a triple-symptom complex of recurrent oral aphthous ulcers, genital ulcers, and uveitis. [1] The systemic manifestations can be variable. Ocular disease has ...

Oct 6th, 2022 - Practice Essentials Behçet disease is a rare vasculitic disorder that is characterized by a triple-symptom complex of recurrent oral aphthous ulcers, genital ulcers, and uveitis. [1] The systemic manifestations can be variable. Ocular disease has ...

Mar 17th, 2022 - Background: Vulvar aphthous ulcers have been described since the early 1900s. These non-sexually acquired genital ulcers typically appear in the perimenarchal population as 1-3 painful ulcers that spontaneously resolve within 21 days. Etiology is ...

Jun 9th, 2022 - The combination of diclofenac and propolis could enhance the healing of recurrent aphthous ulcers, instantly relieve symptoms, improve the quality of life, and present a de novo and cost-effective regime help in oral ulcer treatment. This study ai...

Mar 31st, 2022 - Eligible study subjects will be randomized into two groups 8-18 weeks after surgery. One group will be maintained on tacrolimus according to the standard of care at our center. In the second group tacrolimus will be converted to sirolimus, with on...

Mar 17th, 2022 - Background: Vulvar aphthous ulcers have been described since the early 1900s. These non-sexually acquired genital ulcers typically appear in the perimenarchal population as 1-3 painful ulcers that spontaneously resolve within 21 days. Etiology is ...

Nov 4th, 2021 - Aphthous ulcers of the mouth or esophagus can interfere with eating, resulting in malnutrition and wasting. Thalidomide has been proposed as an effective therapy for severe forms of aphthous ulceration in AIDS patients. Patients are randomized to ...

Sep 2nd, 2021 - Background: oral ulceration is the earliest and commonest manifestation of Behcet's disease (BD). Minor aphthous like ulcers (<10 mm in diameter) are the most common type (85%); major or herpetiform ulcers are less frequent. It is occurred about i...

Mar 17th, 2022 - Background: Vulvar aphthous ulcers have been described since the early 1900s. These non-sexually acquired genital ulcers typically appear in the perimenarchal population as 1-3 painful ulcers that spontaneously resolve within 21 days. Etiology is ...

Apr 2nd, 2021 - Transcript:Adam M. Brufsky, MD: Right. So the last thing we’ll talk about in terms of these targeted therapies is we have one that’s already been approved. Where does it fit in now, I guess it’s the old school one, this is old school which is ever...

Mar 30th, 2021 - The European Commission (EC) has granted marketing clearance for risdiplam (Evrysdi, PTC Therapeutics), the first oral treatment for patients with certain types of spinal muscular atrophy (SMA). Risdiplam is indicated for the treatment of 5q SMA i...

Mar 1st, 2021 - The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended marketing authorization for risdiplam (Evrysdi), the first treatment that can be given orally to patients with certain types of spinal...

Jun 22nd, 2020 - Apremilast was highly effective in treating patients with severe recurrent aphthous stomatitis, with rapid response and an excellent safety profile, results from a small pilot study showed. Dr.